Your session is about to expire
← Back to Search
Guided Metoprolol Management for Atrial Fibrillation (PREEMPTIVE Trial)
PREEMPTIVE Trial Summary
This trial is investigating whether personalized recommendations for the drug metoprolol, based on a patient's genetic makeup, will be more effective in reducing postoperative atrial fibrillation than the standard dosing recommendations.
- Post-operative Atrial Fibrillation
PREEMPTIVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPREEMPTIVE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 10251 Patients • NCT00000620PREEMPTIVE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment available for this clinical trial?
"Affirmative. According to the information on clinicaltrials.gov, recruitment is currently underway for this medical trial which was first posted on March 5th 2021 and recently modified on March 10th 2022. The study needs 400 participants from one site in order to reach completion."
What is the estimated size of participation in this medical experiment?
"Yes, the information confirms that this clinical trial is still in search of volunteers. First posted on March 5th 2021 and most recently updated on March 10th 2022, 400 individuals are needed to participate at a single location."
Share this study with friends
Copy Link
Messenger